[HTML][HTML] Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification

H Mei, S Cai, D Huang, H Gao, J Cao, B He - Bioactive materials, 2022 - Elsevier
The considerable development of carrier-free nanodrugs has been achieved due to their
high drug-loading capability, simple preparation method, and offering “all-in-one” functional …

Nanoparticle formulations of cisplatin for cancer therapy

X Duan, C He, SJ Kron, W Lin - Wiley Interdisciplinary Reviews …, 2016 - Wiley Online Library
The genotoxic agent cisplatin, used alone or in combination with radiation and/or other
chemotherapeutic agents, is an important first‐line chemotherapy for a broad range of …

Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy

Q Sun, H Bi, Z Wang, C Li, X Wang, J Xu, H Zhu… - Biomaterials, 2019 - Elsevier
Drug delivery systems (DDSs) have emerged to help delivering the required cargo into the
region of the tumor, achieving the objectives of extenuating the potential damage to the body …

A native drug-free macromolecular therapeutic to trigger mutual reinforcing of endoplasmic reticulum stress and mitochondrial dysfunction for cancer treatment

W Wang, Y Zhang, Z Wang, X Liu, S Lu, X Hu - ACS nano, 2023 - ACS Publications
Drug-free macromolecular therapeutics are promising alternatives to traditional drugs.
Nanomedicines with multiple organelles targeting can potentially increase the efficacy …

Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics

XW Hua, YW Bao, Z Chen, FG Wu - Nanoscale, 2017 - pubs.rsc.org
We prepare for the first time a novel type of fluorescent carbon quantum dot (or carbon dot,
CD) with intrinsic mitochondrial targeting ability by a one-step hydrothermal treatment of …

Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment

G Battogtokh, YY Cho, JY Lee, HS Lee… - Frontiers in …, 2018 - frontiersin.org
The mitochondrion is an important intracellular organelle for drug targeting due to its key
roles and functions in cellular proliferation and death. In the last few decades, several …

Tumor-and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis

H Wang, F Zhang, H Wen, W Shi, Q Huang… - Journal of …, 2020 - Springer
Chemotherapeutic drugs frequently encounter multidrug resistance. ATP from mitochondria
helps overexpression of drug efflux pumps to induce multidrug resistance, so mitochondrial …

Future of nanotherapeutics: Targeting the cellular sub-organelles

X Ma, N Gong, L Zhong, J Sun, XJ Liang - Biomaterials, 2016 - Elsevier
Many diseases originate from alterations at nanoscale levels. Precise drug delivery should
be achieved not only at cell level, but also at organelle level to achieve maximum …

Mitochondria-targeting polydopamine nanoparticles to deliver doxorubicin for overcoming drug resistance

WQ Li, Z Wang, S Hao, H He, Y Wan… - … applied materials & …, 2017 - ACS Publications
Mitochondria play a critical role in diverse cellular processes, such as energy production
and apoptosis regulation. The mitochondria-targeted drug delivery is becoming a potential …

Two‐dimensional nanomaterials for cancer nanotheranostics

Y Chen, Y Wu, B Sun, S Liu, H Liu - Small, 2017 - Wiley Online Library
Emerging nanotechnologies show unprecedented advantages in accelerating cancer
theranostics. Among them, two‐dimensional nanomaterials (2DNMs) represent a novel type …